help button home button Am J Pathol Epitomics, Inc.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Simian, M.
Right arrow Articles by Lanari, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Simian, M.
Right arrow Articles by Lanari, C.
(American Journal of Pathology. 2006;168:270-279.)
© 2006 American Society for Investigative Pathology

Involvement of Matrix Metalloproteinase Activity in Hormone-Induced Mammary Tumor Regression

Marina Simian, Alfredo Molinolo and Claudia Lanari

From the Laboratorio de Carcinogénesis Hormonal, Instituto de Biología y Medicina Experimental, Consejo Nacional de Investigaciones Científicas y Técnicas, Buenos Aires, Argentina

Proteolytic activity and remodeling of the extracellular matrix are important players in tumor progression. However, to date the role of the extracellular matrix in tumor regression remains unresolved. To address this, we used a progesterone-dependent in vivo mouse mammary tumor line, C4-HD, which regresses in response to hormone therapy. Within the first 72 hours of treatment, massive apoptosis was accompanied by changes in the staining patterns of laminin and collagens I, III, and IV. We thus hypothesized that an increase in matrix metalloproteinase (MMP) activity could be involved in this process. This indeed was the case as the activities of MMP-2, -9, and -3 increased in regressing tumors, coinciding with the peak of apoptosis. Moreover, cell-cell interactions were disrupted during early hours of regression with E-cadherin levels reduced and fragmentation products detected during regression. Analysis of ß-catenin revealed that although total levels within the tissue did not change, this molecule switched from being involved in cell-cell adhesion in the growing tumor to being expressed in the reactive stroma during regression. Our data provide a novel role for proteolytic activity in tumor regression and question the underlying principle for using MMP inhibitors in cancer treatment.





This article has been cited by other articles:


Home page
Endocr Relat CancerHome page
C. Lanari, C. A Lamb, V. T Fabris, L. A Helguero, R. Soldati, M. C. Bottino, S. Giulianelli, J. P. Cerliani, V. Wargon, and A. Molinolo
The MPA mouse breast cancer model: evidence for a role of progesterone receptors in breast cancer
Endocr. Relat. Cancer, June 1, 2009; 16(2): 333 - 350.
[Abstract] [Full Text] [PDF]


Home page
Anticancer ResHome page
S. AUGUSTIN, M. BERARD, S. KELLAF, N. PEYRI, F. FAUVEL-LAFEVE, C. LEGRAND, L. HE, and M. CREPIN
Matrix Metalloproteinases Are Involved in Both Type I (Apoptosis) and Type II (Autophagy) Cell Death Induced by Sodium Phenylacetate in MDA-MB-231 Breast Tumour Cells
Anticancer Res, April 1, 2009; 29(4): 1335 - 1343.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
C. J. Proietti, C. Rosemblit, W. Beguelin, M. A. Rivas, M. C. Diaz Flaque, E. H. Charreau, R. Schillaci, and P. V. Elizalde
Activation of Stat3 by Heregulin/ErbB-2 through the Co-Option of Progesterone Receptor Signaling Drives Breast Cancer Growth
Mol. Cell. Biol., March 1, 2009; 29(5): 1249 - 1265.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the American Society for Investigative Pathology.